Nathalie Adda Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nathalie Adda.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nathalie Adda. Nathalie Adda is Sr. VP & Chief Medical Officer in ENANTA PHARMACEUTICALS INC ($ENTA).
Latest Insider Trading Transactions of Nathalie Adda
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 0.00 | 5,250 | 0 | 0 | |
Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 42.52 | 1,540 | 65,481 | 26,944 | 28.5 K to 26.9 K (-5.41 %) |
Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 0.00 | 5,250 | 0 | 28,484 | 23.2 K to 28.5 K (+22.60 %) |
Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 43.57 | 30,800 | 1,341,956 | 30,800 | |
Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 7,600 | 0 | 23,234 | 15.6 K to 23.2 K (+48.61 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 52.76 | 1,091 | 57,561 | 15,634 | 16.7 K to 15.6 K (-6.52 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 2,925 | 0 | 16,725 | 13.8 K to 16.7 K (+21.20 %) |
Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 487 | 0 | 13,800 | 13.3 K to 13.8 K (+3.66 %) |
Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 0.00 | 5,250 | 0 | 5,250 | |
Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 63.88 | 2,331 | 148,904 | 13,313 | 15.6 K to 13.3 K (-14.90 %) |
Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 0.00 | 5,250 | 0 | 15,644 | 10.4 K to 15.6 K (+50.51 %) |
Nov 18 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 63.35 | 30,000 | 1,900,500 | 30,000 | |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 88.88 | 5,356 | 476,041 | 10,394 | 15.8 K to 10.4 K (-34.01 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 88.88 | 5,356 | 476,041 | 10,394 | 15.8 K to 10.4 K (-34.01 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 11,250 | 0 | 15,750 | 4.5 K to 15.8 K (+250.00 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 11,250 | 0 | 15,750 | 4.5 K to 15.8 K (+250.00 %) |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
Nov 20 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 81.20 | 20,000 | 1,624,000 | 20,000 | |
Sep 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 43.46 | 2,955 | 128,424 | 72,270 | |
Sep 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 96.89 | 1,371 | 132,842 | 0 | 1.4 K to 0 (-100.00 %) |
Sep 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 95.84 | 602 | 57,699 | 1,371 | 2 K to 1.4 K (-30.51 %) |
Sep 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 94.75 | 1,229 | 116,451 | 1,973 | 3.2 K to 2 K (-38.38 %) |
Sep 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 93.90 | 453 | 42,535 | 3,202 | 3.7 K to 3.2 K (-12.39 %) |
Sep 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 93.02 | 500 | 46,509 | 3,655 | 4.2 K to 3.7 K (-12.03 %) |
Sep 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 43.46 | 2,955 | 128,424 | 4,155 | 1.2 K to 4.2 K (+246.25 %) |
Aug 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 43.46 | 2,955 | 128,424 | 75,225 | |
Aug 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 93.49 | 659 | 61,613 | 310 | 969 to 310 (-68.01 %) |
Aug 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 92.68 | 2,224 | 206,130 | 969 | 3.2 K to 969 (-69.65 %) |
Aug 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 91.49 | 700 | 64,042 | 3,193 | 3.9 K to 3.2 K (-17.98 %) |
Aug 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 90.58 | 572 | 51,812 | 3,893 | 4.5 K to 3.9 K (-12.81 %) |
Aug 21 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 43.46 | 2,955 | 128,424 | 4,465 | 1.5 K to 4.5 K (+195.70 %) |
Jul 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 43.46 | 2,955 | 128,424 | 78,180 | |
Jul 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 126.40 | 904 | 114,261 | 1,510 | 2.4 K to 1.5 K (-37.45 %) |
Jul 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 125.60 | 1,621 | 203,602 | 2,414 | 4 K to 2.4 K (-40.17 %) |
Jul 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 124.20 | 445 | 55,269 | 4,035 | 4.5 K to 4 K (-9.93 %) |
Jul 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 123.72 | 2,075 | 256,710 | 4,480 | 6.6 K to 4.5 K (-31.66 %) |
Jul 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 43.46 | 2,955 | 128,424 | 6,555 | 3.6 K to 6.6 K (+82.08 %) |
Jun 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 43.46 | 2,955 | 128,424 | 81,135 | |
Jun 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 115.89 | 658 | 76,254 | 3,600 | 4.3 K to 3.6 K (-15.45 %) |
Jun 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 115.09 | 2,229 | 256,542 | 4,258 | 6.5 K to 4.3 K (-34.36 %) |
Jun 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 113.90 | 1,268 | 144,426 | 6,487 | 7.8 K to 6.5 K (-16.35 %) |
Jun 19 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 43.46 | 2,955 | 128,424 | 7,755 | 4.8 K to 7.8 K (+61.56 %) |
May 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 43.46 | 2,955 | 128,424 | 84,090 | |
May 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 105.57 | 2,955 | 311,951 | 4,800 | 7.8 K to 4.8 K (-38.10 %) |
May 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 104.81 | 800 | 83,844 | 7,755 | 8.6 K to 7.8 K (-9.35 %) |
May 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 103.85 | 400 | 41,538 | 8,555 | 9 K to 8.6 K (-4.47 %) |
May 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 43.46 | 2,955 | 128,424 | 8,955 | 6 K to 9 K (+49.25 %) |
Apr 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 43.46 | 2,955 | 128,424 | 87,045 | |
Apr 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 85.92 | 2,425 | 208,354 | 6,000 | 8.4 K to 6 K (-28.78 %) |
Apr 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Sell | S | 85.11 | 1,800 | 153,205 | 8,425 | 10.2 K to 8.4 K (-17.60 %) |
Apr 18 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 43.46 | 2,955 | 128,424 | 10,225 | 7.3 K to 10.2 K (+40.65 %) |
Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 76.85 | 2,566 | 197,184 | 7,270 | 9.8 K to 7.3 K (-26.09 %) |
Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 6,028 | 0 | 9,836 | 3.8 K to 9.8 K (+158.30 %) |
Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 2,500 | 0 | 3,808 | 1.3 K to 3.8 K (+191.13 %) |
Nov 21 2017 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 48.52 | 23,500 | 1,140,220 | 23,500 | |
Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 29.82 | 792 | 23,613 | 1,308 | 2.1 K to 1.3 K (-37.71 %) |
Feb 15 2017 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 2,100 | 0 | 2,100 | 0 to 2.1 K |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
Nov 22 2016 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 30.00 | 35,000 | 1,050,000 | 35,000 | |
Nov 24 2015 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 31.42 | 16,000 | 502,720 | 16,000 | |
Jul 01 2015 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 43.46 | 90,000 | 3,911,400 | 90,000 |
Page: 1